Home/Massachusetts Superior Court/Medmarc Casualty Insurance Company v. Harvard Bioscience, Inc. and Biostage, Inc.

Medmarc Casualty Insurance Company v. Harvard Bioscience, Inc. and Biostage, Inc.

Massachusetts Superior Court·Decided May 18, 2022·No. 2184CV02093-BLS2·Published

Opinion

SUPERIOR COURT

MEDMARC CASUALTY INSURANCE COMPANY v. HARVARD BIOSCIENCE, INC. AND BIOSTAGE, INC.

Docket: 2184CV02093-BLS2
Dates: January 24, 2022
Present: Kenneth W. Salinger Justice of the Superior Court
County: SUFFOLK, ss.
Keywords: PRELIMINARY INJUNCTION

Medmarc Casualty Insurance Company and its officers, employees, and agents are hereby ordered and enjoined, until further order by the court, to pay all Defense Expenses that are incurred by Biostage, Inc., or Harvard Bioscience, Inc., on or after September 30, 2021, in connection with Suffolk Superior Court civil action no. 1784CV01147 (which is titled Husamettin Akkus and Perry Ganz, as Co-Personal Representatives of the Estate of Yesim Cetir v. Harvard Bio Science, Inc., and others), in accord with Medmarc’s Policy Number 16MA380035.

Free access — add to your briefcase to read the full text and ask questions with AI

Medmarc Casualty Insurance Company v. Harvard Bioscience, Inc. and Biostage, Inc., (Mass. Ct. App. 2022).

Medmarc Casualty Insurance Company v. Harvard Bioscience, Inc. and Biostage, Inc. (Medmarc Casualty Insurance Company v. Harvard Bioscience, Inc. and Biostage, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.